Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Table. 3.

Effect of prunetin on the levels of liver marker enzymes in serum control and experimental rats

Groups SGOT (U/L) SGPT (U/L) ALP (U/L)
Control 26.68 ± 1.88 22.33 ± 1.83 73.73 ± 3.22
STZ (diabetic control) 96.85 ± 1.33* 106.31 ± 4.38* 174.39 ± 3.78*
PRU 80 mg/kg 29.95 ± 0.83 21.78 ± 3.27 75.16 ± 4.10
STZ+PRU 20 mg/kg 83.53 ± 2.68# 75.24 ± 1.70# 142.06 ± 2.88#
STZ+PRU 40 mg/kg 65.84 ± 3.72# 56.27 ± 5.22# 120.26 ± 3.30#
STZ+PRU 80 mg/kg 30.65 ± 1.09## 25.12 ± 1.35## 76.08 ± 1.75##

Values are expressed as means ± SD (n=6 rats for each group; test were performed in triplicate). *p<0.05 versus Control group; #p<0.05, ##p<0.01 versus STZ (diabetic control group).

Biomolecules & Therapeutics 2023;31:619~628 https://doi.org/10.4062/biomolther.2023.068
© Biomolecules & Therapeutics